EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $291,819 | -76.4% | 28,893 | -76.8% | 0.05% | -68.5% |
| Q3 2022 | $1,238,000 | +1.2% | 124,800 | -0.2% | 0.16% | +9.3% |
| Q2 2022 | $1,223,000 | +0.2% | 125,000 | 0.0% | 0.15% | +14.4% |
| Q1 2022 | $1,221,000 | +0.7% | 125,000 | 0.0% | 0.13% | +120.0% |
| Q4 2021 | $1,213,000 | -0.1% | 125,000 | 0.0% | 0.06% | +30.4% |
| Q3 2021 | $1,214,000 | +0.5% | 125,000 | 0.0% | 0.05% | 0.0% |
| Q2 2021 | $1,208,000 | – | 125,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |